ํธ๋ ํ๋ฏผ / ์กธ๋ผ์ ํ
**ํธ๋ ํ๋ฏผ/์กธ๋ผ์ ํ**(์ผ๋ฐ์ ์ธ ์ํ๋ช : **Telazolยฎ**)์ ์์ํ์์ ๋๋ฆฌ ์ฌ์ฉ๋๋ ์ฃผ์ฌ์ฉ ๋ง์ทจ ๋ฐ ์ง์ ์ ๋ณตํฉ์ ์ ๋๋ค. ๋ ๊ฐ์ง ๋ค๋ฅธ ์ฝ๋ฆฌํ์ ์ ์ ๊ฐ 1:1 ๋น์จ๋ก ํผํฉ๋์ด ์์ต๋๋ค: * **ํธ๋ ํ๋ฏผ**: ์ผํ๋ฏผ๊ณผ ํํ์ ์ผ๋ก ๊ด๋ จ๋ ํด๋ฆฌ์ฑ ๋ง์ทจ์ ๋ก, ๊น์ ์งํต๊ณผ ๊ธฐ์ต ์์ค ํจ๊ณผ๋ฅผ ์ ๊ณตํฉ๋๋ค. * **์กธ๋ผ์ ํ**: ๋ฒค์กฐ๋์์ ํ๊ณ ์ฝ๋ฌผ๋ก ๊ทผ์ก ์ด์, ํญ๋ถ์ ์์ฉ์ ์ ๊ณตํ๋ฉฐ ํด๋ฆฌ์ฑ ๋ง์ทจ์ ๋จ๋ ์ฌ์ฉ ์ ํํ ๋ฐ์ํ๋ ๊ทผ์ก ๊ฒฝ์ง ๋ฐ ๋ฐ์ ์ํ์ ์์ํฉ๋๋ค. ๊ฐ์ ๊ณ ์์ด์ ๋ณด์ , ๊ฐ๋จํ ์์ ๋ฐ ๋ง์ทจ์ฉ์ผ๋ก FDA์ ๊ณต์ ์น์ธ์ ๋ฐ์์ผ๋, ๋ง, ๋ฐ์ถ๋๋ฌผ, ๋ผ์ง, ์กฐ๋ฅ, ํ์ถฉ๋ฅ ๋ฐ ๋ค์ํ ํน์/์ผ์ ๋๋ฌผ์๊ฒ ์คํ๋ผ๋ฒจ๋ก ๊ด๋ฒ์ํ๊ฒ ์ฌ์ฉ๋ฉ๋๋ค. > **์์ ์์ :** ๋ ์ฑ๋ถ์ ์์ฉ ์๊ฐ์ ์ข ์ ๋ฐ๋ผ ๋ค๋ฆ ๋๋ค. **๊ฐ**์ ๊ฒฝ์ฐ ํธ๋ ํ๋ฏผ์ด ์กธ๋ผ์ ํ๋ณด๋ค ์ค๋ ์ง์๋์ด ๋ง์ทจ ์๊ฐ๋ณด๋ค ์ง์ ์๊ฐ์ด ์งง์์ง๋๋ค(ํ๋ณต๊ธฐ๊ฐ ๋ค์ ๊ฑฐ์น ์ด์ง ์ ์์). **๊ณ ์์ด**์ ๊ฒฝ์ฐ ์กธ๋ผ์ ํ์ด ํธ๋ ํ๋ฏผ๋ณด๋ค ์ค๋ ์ง์๋์ด ํ๋ณต๊ธฐ ๋์ ๋ ๊ธด ์ง์ ์ํ๋ฅผ ์ ์งํฉ๋๋ค.
์์ฉ ๊ธฐ์ : The combination works synergistically through two distinct central nervous system pathways: * **Tiletamine** acts as a non-competitive **NMDA (N-methyl-D-aspartate) receptor antagonist**. By blocking the excitatory neurotransmitter glutamate at the NMDA receptor โ it prevents calcium influx into neurons โ inducing a state of **dissociative anesthesia** characterized by catalepsy, profound somatic analgesia, and amnesia, while maintaining cranial nerve reflexes (e.g., palpebral, laryngeal). * **Zolazepam** acts as a **GABA-A receptor agonist**. It binds to the benzodiazepine site on the GABA-A receptor complex โ enhances the binding of the inhibitory neurotransmitter GABA โ increases chloride ion influx โ resulting in hyperpolarization of the neuron. This provides **muscle relaxation, anxiolysis, and anticonvulsant effects**, smoothing the induction and recovery phases of the dissociative anesthetic.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Induction agent ยท Xylazine at 0.05-0.1 mg/kg IV, IM, then Telazol at 2-4 mg/kg IV (IM) ยท IV/IM ยท Once ยท Caution: xylazine can cause severe hypoxemia and pulmonary edema in sheep.
- Induction agent ยท Xylazine at 0.05-0.1 mg/kg IV, IM, then Telazol at 2-4 mg/kg IV (IM) ยท IV/IM ยท Once
- Procedures such as dentistry, abscess treatment, foreign body removal ยท 9.7-11.9 mg/kg ยท IM ยท Once ยท Max total dose 72 mg/kg. Use Atropine 0.04 mg/kg concurrently.
- Procedures requiring mild to moderate analgesia (lacerations, castration) ยท 10.6-12.5 mg/kg ยท IM ยท Once ยท Max total dose 72 mg/kg. Use Atropine 0.04 mg/kg concurrently.
- Ovariohysterectomy and onychectomy ยท 14.3-15.8 mg/kg ยท IM ยท Once ยท Max total dose 72 mg/kg. Use Atropine 0.04 mg/kg concurrently.
- General anesthesia/restraint ยท 3-10 mg/kg IM or SC or 2-5 mg/kg IV ยท IM/SC/IV ยท Once ยท Based upon the combination of drugs.
- Sedative/analgesic ยท 22 mg/kg IM combined with glycopyrrolate (0.01 mg/kg IM) ยท IM ยท Once ยท Rapid onset, but slow and rough recovery (3-4 hours)
- Sedative/analgesic ยท 22 mg/kg ยท IM ยท Once ยท Telazol alone
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Pancreatic disease
- Severe cardiac disease
- Severe pulmonary disease
- Rabbits (due to reports of renal toxicity/nephrosis)
- Large exotic cats, especially tigers (may cause seizures, permanent neurologic abnormalities, or death)
- Cesarean section (crosses placenta, causes fetal respiratory depression)
์ด์๋ฐ์
- Respiratory depression and transient apnea
- Pain upon IM injection (especially in cats due to low pH)
- Athetoid movements (involuntary writhing/twitching)
- Tachycardia (especially in dogs)
- Emesis during emergence
- Excessive salivation and bronchial/tracheal secretions
- Vocalization and erratic/prolonged recovery
- Hypothermia
- Muscle rigidity or hypertonia
- Hypertension or hypotension
- Cyanosis, pulmonary edema, or cardiac arrest (rare/at high doses)
์ฝ๋ฌผ ์ํธ์์ฉ
- Inhalational Anesthetics ยท Dosage may need to be reduced when used concomitantly with Telazol.
- Barbiturates ยท Dosage may need to be reduced when used concomitantly with Telazol.
- Chloramphenicol ยท In cats, anesthesia is prolonged on average by 30 minutes. No apparent effect on recovery times in dogs.
- Phenothiazines ยท Can cause increased respiratory and cardiac depression.
- Neuromuscular Blockers (e.g., succinylcholine) ยท May cause enhanced or prolonged respiratory depression (extrapolated from ketamine).
- Thyroid Hormones ยท May induce hypertension and tachycardia (extrapolated from ketamine).
- Azole Antifungals (ketoconazole, itraconazole) ยท May increase zolazepam (benzodiazepine) levels.
- Calcium Channel Blockers (diltiazem, verapamil) ยท May increase zolazepam levels.
- Cimetidine ยท May increase zolazepam levels.
- Macrolides (erythromycin, clarithromycin) ยท May increase zolazepam levels.
- Opiates ยท May increase hypnotic effects and risk of hypotension/respiratory depression.
- Phenobarbital ยท May decrease peak levels and AUC of zolazepam.
๋ชจ๋ํฐ๋ง
- Level of anesthesia and analgesia
- Respiratory function (rate, depth, pulse oximetry)
- Cardiovascular status (heart rate, rhythm, blood pressure)
- Body temperature (monitor for hypothermia)
- Eye moisture and corneal integrity (especially in cats)
๊ณผ์ฉ๋
The manufacturer claims a 2X margin of safety in dogs and a 4.5X margin of safety in cats. * **Clinical Signs:** Excessive respiratory depression, prolonged anesthesia, potential cardiovascular collapse. * **Treatment:** In massive overdoses, mechanically assisted ventilation should be performed if necessary. Treat other clinical signs symptomatically and supportively. * **Reversal/Stimulation:** A preliminary study in dogs suggests that **doxapram** at 5.5 mg/kg will enhance respirations and arousal after Telazol administration. > **Note:** High doses of tiletamine have caused acute tubular necrosis in New Zealand white rabbits.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.